LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

LLY

949.03

+1.48%↑

NVO

142.18

+1.62%↑

UNH

511.99

+1.33%↑

JNJ

149.82

+0.04%↑

MRK

127.38

-1.16%↓

Search

Axonics Inc

Fermé

Secteur Soins de santé

67.84 -0.15

Résumé

Variation du prix de l'action

24h

Actuel

Min

67.7

Max

67.89

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+4.72 upside

Dividendes

By Dow Jones

Prochains Résultats

25 juil. 2024

Sentiment de l'Actualité

By Acuity

21%

79%

32 / 369 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Axonics Inc Graphique

Actualités Associées

8 janv. 2024, 16:21 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

Axonics Shares Climb 20% After Acquisition by Boston Scientific

8 janv. 2024, 12:26 UTC

Acquisitions, Fusions, Rachats

Boston Scientific To Acquire Axonics For About $3.7 Billion

8 janv. 2024, 15:59 UTC

Acquisitions, Fusions, Rachats

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot' -- IBD

8 janv. 2024, 14:19 UTC

Acquisitions, Fusions, Rachats

J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value -- IBD

8 janv. 2024, 13:18 UTC

Acquisitions, Fusions, Rachats

Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal. -- Barrons.com

8 janv. 2024, 12:12 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Acquisition Impact to GAAP EPS Expected to Be Less Accretive, or More Dilutive, Due to Amortization Expense and Acquisition-Related Net Charges >BSX

8 janv. 2024, 12:12 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Sees Acquisition Impact to Adj EPS Immaterial in 2024 and Accretive Thereafter >BSX

8 janv. 2024, 12:11 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Axonics' Rev Growth Profile Is Anticipated to Be Highly Accretive to BSX Urology Business in 2024 >BSX

8 janv. 2024, 12:11 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Axonics Expects to Deliver Net Rev of About $366 M in 2023 >BSX

8 janv. 2024, 12:11 UTC

Actualités
Acquisitions, Fusions, Rachats

Boston Scientific To Acquire Axonics For About $3.7 Bln

8 janv. 2024, 12:10 UTC

Acquisitions, Fusions, Rachats

Axonic's Stock Soars After Cash Buyout Deal With Boston Scientific Valued At $3.7 Billion -- MarketWatch

8 janv. 2024, 12:02 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Deal Reflects Equity Value of About $3.7B and Enterprise Value of About $3.4B

8 janv. 2024, 12:02 UTC

Acquisitions, Fusions, Rachats

Boston Scientific: Acquisition to Expand Urology Portfolio With Differentiated Technologies to Treat Urinary and Bowel Dysfunction >BSX

8 janv. 2024, 12:02 UTC

Acquisitions, Fusions, Rachats

Boston Scientific to Buy Axonics for $71 in Cash Per Share >BSX AXNX

8 janv. 2024, 12:01 UTC

Acquisitions, Fusions, Rachats

Axonics to Be Acquired for $71/Share; Closed Friday at $57.57 >BSX AXNX

8 janv. 2024, 12:01 UTC

Acquisitions, Fusions, Rachats

Axonics to Be Acquired by Boston Scientific for About $3.7 Billion >BSX AXNX

8 janv. 2024, 12:01 UTC

Acquisitions, Fusions, Rachats

Axonics to Be Acquired by Boston Scientific for $71/Share Cash >BSX AXNX

8 janv. 2024, 12:00 UTC

Acquisitions, Fusions, Rachats

Boston Scientific Announces Agreement To Acquire Axonics, Inc. >BSX AXNX

8 janv. 2024, 12:00 UTC

Acquisitions, Fusions, Rachats

Axonics Announces Definitive Agreement To Be Acquired By Boston Scientific >AXNX BSX

Comparaison

Variation de prix

Axonics Inc prévision

Objectif de Prix

By TipRanks

4.72% hausse

Prévisions sur 12 Mois

Moyen 71 USD  4.72%

Haut 71 USD

Bas 71 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

3 ratings

0

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

67.4 / 67.93Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Bullish Evidence

Long Terme

Weak Bullish Evidence

Sentiment

By Acuity

32 / 369Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne